• Copper-Doped Bioactive Glass Drives Mitophagy and Bone Regen

  2026-06-19

  This study demonstrates that copper-doped mesoporous bioactive glass nanoparticles (Cu-MBGNs) accelerate bone regeneration by promoting osteoblast mitophagy and regulating mitochondrial dynamics. The work uncovers the mechanistic link between Cu-MBGNs, matrix vesicle-mediated biomineralization, and enhanced bone repair, offering new directions for advanced biomaterial design.

• Bestatin Hydrochloride: Mechanism and Evidence in Angiogenes

  2026-06-19

  Bestatin hydrochloride (Ubenimex) is a validated inhibitor of aminopeptidase N and B with established roles in angiogenesis inhibition and tumor growth research. Its precise mechanism and workflow parameters make it a reproducible tool in cancer and neuropeptide studies.

• Clodronate Liposomes: Precision In Vivo Macrophage Depletion

  2026-06-18

  Clodronate Liposomes empower researchers with a robust, scalable reagent for targeted in vivo macrophage depletion across diverse models. Their versatile administration routes and proven reliability enable clear dissection of immune cell functions, as recently demonstrated in liver injury and polarization studies.

• TRPV1 Antagonism for Ocular Surface Pain: Pharmacology of SA

  2026-06-18

  This study delineates the pharmacological properties and safety profile of SAF312 (Libvatrep), a selective and potent TRPV1 antagonist for the potential topical treatment of ocular surface pain (OSP). The findings establish SAF312’s high selectivity, effective inhibition of TRPV1-mediated responses, and favorable tolerability without impairing corneal wound healing, offering a promising therapeutic avenue where current options are limited.

• Gamithromycin: Applied Protocols for Respiratory Pathogen Re

  2026-06-17

  Gamithromycin (ML-1709460) delivers robust, tissue-targeted activity and reproducible results for translational respiratory infection models. This article details evidence-backed workflows, troubleshooting, and protocol refinements to accelerate experimental success in veterinary and comparative infectious disease research.

• Sunitinib in RCC: Mechanisms, Resistance, and Future Strateg

  2026-06-17

  This thought-leadership article explores the mechanistic insights and translational research strategies surrounding sunitinib, a multi-targeted receptor tyrosine kinase inhibitor, in the context of renal cell carcinoma (RCC). Integrating new evidence on overcoming resistance via ferroptosis induction, we provide actionable guidance for researchers seeking to advance anti-angiogenic therapies and combinatorial approaches.

• ONC201 Disrupts Metabolic and Epigenetic Networks in H3K27M-

  2026-06-16

  The referenced study demonstrates that ONC201 extends survival in patients with H3K27M-mutant diffuse midline gliomas by targeting interconnected metabolic and epigenetic pathways. This mechanistic insight establishes a rationale for ONC201's clinical efficacy and highlights the need for rigorous methods to preserve protein phosphorylation during such research.

• Small-Molecule uPAR Inhibition Reduces Breast Cancer Metasta

  2026-06-16

  The reference study demonstrates that IPR-803, a competitive urokinase receptor inhibitor, directly disrupts the uPAR–uPA interaction and impairs breast cancer invasion and metastasis. This work details the molecule's biochemical affinity, cellular impact, and in vivo efficacy, providing a validated template for metastasis inhibitor development.

• Applied Use of Apigenin for HDAC Inhibition and Neuroprotect

  2026-06-15

  Apigenin, a plant-derived flavonoid, enables precise modeling of HDAC inhibition and neuroprotective pathways in both cancer and neurodegeneration research. This guide details optimized workflows, advanced applications, and troubleshooting techniques to maximize experimental success with Apigenin from APExBIO.

• Balancing Self-Renewal and Differentiation in Human Intestin

  2026-06-15

  This study presents a tunable human intestinal organoid system that achieves a controlled balance between stem cell self-renewal and differentiation using targeted small molecule pathway modulators. The approach increases cellular diversity and scalability under a single culture condition, creating new opportunities for high-throughput research in tissue development and disease modeling.

• Capsaicin: Dual TRPV1 Activation and KDM1A Inhibition in Res

  2026-06-14

  Capsaicin is a natural vanillamide widely used for its potent activation of the TRPV1 ion channel and selective inhibition of KDM1A/LSD1. Peer-reviewed evidence supports its dual role in pain and itch modeling, as well as cancer cell inhibition, making it essential for translational research.

• WP1066: Advanced JAK2/STAT3 Inhibition for Cancer and Regene

  2026-06-13

  Explore the unique capabilities of WP1066, a potent JAK2/STAT3 inhibitor, in dissecting cancer signaling and modulating regenerative pathways. This in-depth review highlights WP1066's mechanistic depth, optimized assay use, and its distinct value in bridging oncology and tissue repair research.

• Small-Molecule Inhibition of uPAR–uPA Blocks Cancer Cell Inv

  2026-06-12

  Khanna et al. report the discovery of small-molecule inhibitors, including IPR-803 derivatives, that selectively disrupt the uPAR–uPA protein–protein interaction, a critical driver of tumor invasion and metastasis. Their work demonstrates that targeting multiple conformations of uPAR enables effective blockade of cancer cell invasion, providing a mechanistic basis for further development of urokinase receptor inhibitors in cancer research.

• Hydrocortisone in Inflammation Models: Protocols & Insights

  2026-06-12

  Hydrocortisone empowers researchers to dissect glucocorticoid receptor signaling and anti-inflammatory responses with precision. Discover advanced workflows, troubleshooting strategies, and real-world use-cases for inflammation and neuroprotection studies, leveraging APExBIO quality and current translational research.

• Peroxynitrite-Driven ER Stress and Necroptosis in Cardiac I/

  2026-06-11

  Liu et al. (2025) identify a novel mechanism linking hyperhomocysteinemia to cardiac microvascular ischemia-reperfusion injury via peroxynitrite-induced ER stress and pathological calcium transfer, culminating in necroptosis. These findings highlight IP3R-mediated Ca2+ flux as a tractable target for intervention, deepening our understanding of cell death pathways in acute cardiovascular events.

436 records 13/30 page Previous Next First page 上5页 1112131415 下5页 Last page